These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33523597)

  • 41. Paediatric adverse drug reactions following use of asthma medications in Europe from 2007 to 2011.
    Aagaard L; Hansen EH
    Int J Clin Pharm; 2014 Dec; 36(6):1222-9. PubMed ID: 25288145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Traceability of biopharmaceuticals in spontaneous reporting systems: a cross-sectional study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databases.
    Vermeer NS; Straus SM; Mantel-Teeuwisse AK; Domergue F; Egberts TC; Leufkens HG; De Bruin ML
    Drug Saf; 2013 Aug; 36(8):617-25. PubMed ID: 23771794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Important information regarding reporting of adverse drug reactions: a qualitative study.
    Rolfes L; Wilkes S; van Hunsel F; van Puijenbroek E; van Grootheest K
    Int J Pharm Pract; 2014 Jun; 22(3):231-3. PubMed ID: 23937120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Promoting spontaneous adverse drug reaction reporting in hospitals using a hyperlink to the online reporting form: an ecological study in Portugal.
    Ribeiro-Vaz I; Santos C; da Costa-Pereira A; Cruz-Correia R
    Drug Saf; 2012 May; 35(5):387-94. PubMed ID: 22468615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria.
    Awodele O; Aliu R; Ali I; Oni Y; Adeyeye CM
    Pharmacol Res Perspect; 2018 Oct; 6(5):e00427. PubMed ID: 30324768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study.
    Schutte T; van Eekeren R; Richir M; van Staveren J; van Puijenbroek E; Tichelaar J; van Agtmael M
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):17-26. PubMed ID: 29063137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding.
    Soyer J; Necsoiu D; Desjardins I; Lebel D; Bussières JF
    Arch Pediatr; 2019 Oct; 26(7):400-406. PubMed ID: 31611146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic adverse drug reactions in Malaysia: An 18-year review of the national centralized reporting system.
    Lee FY; Wong HS; Chan HK; Mohamed Ali N; Abu Hassan MR; Omar H; Abdul Mutalib NA
    Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1669-1679. PubMed ID: 33064335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adverse reactions to oncologic drugs: spontaneous reporting and signal detection.
    Tuccori M; Montagnani S; Capogrosso-Sansone A; Mantarro S; Antonioli L; Fornai M; Blandizzi C
    Expert Rev Clin Pharmacol; 2015 Jan; 8(1):61-75. PubMed ID: 25363790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are non-serious adverse reactions to psychiatric drugs really non-serious?
    Pozzi M; Bertella S; Cattaneo D; Molteni M; Perrone V; Carnovale C; Antoniazzi S; Clementi E; Radice S
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):394-400. PubMed ID: 23952186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychiatric adverse drug reactions in the paediatric population.
    Ekhart C; Vries T; Hunsel FV
    Arch Dis Child; 2020 Aug; 105(8):749-755. PubMed ID: 32060030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
    Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL;
    Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
    Matos C; van Hunsel F; Joaquim J
    Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year.
    Singh P; Agrawal M; Hishikar R; Joshi U; Maheshwari B; Halwai A
    Indian J Pharmacol; 2017; 49(6):432-437. PubMed ID: 29674797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Named entity recognition from Chinese adverse drug event reports with lexical feature based BiLSTM-CRF and tri-training.
    Chen Y; Zhou C; Li T; Wu H; Zhao X; Ye K; Liao J
    J Biomed Inform; 2019 Aug; 96():103252. PubMed ID: 31323311
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Documentation of penicillin adverse drug reactions in electronic health records: inconsistent use of allergy and intolerance labels.
    Inglis JM; Caughey GE; Smith W; Shakib S
    Intern Med J; 2017 Nov; 47(11):1292-1297. PubMed ID: 28742226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancing Pediatric Adverse Drug Reaction Documentation in the Electronic Medical Record.
    Tillman EM; Suppes SL; Feldman K; Goldman JL
    J Clin Pharmacol; 2021 Feb; 61(2):181-186. PubMed ID: 32776356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database.
    Noda A; Sakai T; Obara T; Miyazaki M; Tsuchiya M; Oyanagi G; Murai Y; Mano N
    BMC Pharmacol Toxicol; 2020 May; 21(1):36. PubMed ID: 32448369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Knowledge creation about adverse drug reactions in the paediatric population].
    Aagaard L
    Ugeskr Laeger; 2013 Feb; 175(6):342-5. PubMed ID: 23402239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015.
    van Hunsel F; de Waal S; Härmark L
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):977-983. PubMed ID: 28524293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.